Sopan Pharmaceuticals Limited is planning to launch its Sopan Pharmaceuticals IPO to the general public, and this is to start from April 15.
The company has received permission to issue 25% of its issued capital, which amounts to Rs 1.71 billion. With this, a total of 4,290,000 units of shares worth Rs 429 million are to be offered to the public.
The company has already allotted:
In the second phase, the remaining 3,474,900 units will be issued to the general public.
The application for investment can be made for a minimum of 10 units and a maximum of 11,000 units. The IPO will close early on April 19. If it is not fully subscribed, it will be open until April 29.
NMB Capital has been selected as the issue manager for this IPO. Applications can be made through all approved banks and financial institutions under C-ASBA and MeroShare.
However, Sopan Pharmaceuticals’ IPO has been assigned a rating of ‘B’ by Care Ratings Nepal, signifying a high-risk investment.
It is suggested to all investors to consider the risk before investing.
Stay connected with NepseTalk for more information on IPO and the stock market.
लोड हुँदैछ...
0 Comments